Results 61 to 70 of about 15,817 (237)
Heart phantom with electrical properties of heart muscle tissue
The weakened heart is supported by a left ventricular assist device (LVAD) to supply the heart muscle with oxygenated blood. In case the heart muscle recovers during LVAD therapy, the patient has to be weaned from the device.
Korn Leonie +6 more
doaj +1 more source
Validity and reliability of the left ventricular assist device self-care behaviour scale.
BackgroundAdequate self-care behaviour is essential for patients with a left ventricular assist device (LVAD) to prevent complications, prolong life, and optimise quality of life. However, there were no valid and reliable measurements available to assess
Naoko P Kato +7 more
doaj +1 more source
Direct intraoperative HeartMate 3 LVAD flow measurements using an ultrasonic probe revealed consistently higher values by approximately 0.5 L/min compared to device‐estimated flows. This discrepancy remained stable across pump speed settings, highlighting the importance of distinguishing measured from estimated flow in HeartMate 3 patients.
Gaik Nersesian +13 more
wiley +1 more source
Mitral regurgitation changes after LVAD implantation: a numerical study.
Aim: Although the left ventricular (LV) unloading due to LVAD, in some patients (PTs) with severe mitral regurgitation (MR) and severe LV and left atrium dilation,a suboptimal results of LVAD implantation, characterized by persistent relevant MR ...
Frigerio, Maria +7 more
core +1 more source
Recent Developments in Ventricular Assist Device Therapy
The evolution of left ventricular assist devices (LVADs) from large, pulsatile systems to compact, continuous-flow pumps has significantly improved implantation outcomes and patient mobility. Minimally invasive surgical techniques have emerged that offer
Angel Moctezuma-Ramirez +3 more
doaj +1 more source
This study aims to evaluate the potential of a multistage pump design to enhance hemocompatibility in left ventricular assist devices. We found that the two‐stage concept offers favorable hemolysis measures compared to single‐stage designs, as the reduction in peak shear stresses outweighs the disadvantage associated with prolonged residence time ...
Sarah Linnemeier +6 more
wiley +1 more source
Aim. To study mortality, postoperative complications, clinical course, and quality of life of patients with heart failure (HF) within 6 months after left ventricular assist device (LVAD) implantation.Material and methods.
Zh. A. Shakhramanova +10 more
doaj +1 more source
Shear‐induced blood damage—including hemolysis, platelet and neutrophil injury, and von Willebrand factor (vWF) degradation—was evaluated for the BrioVAD and HM3 using an in vitro circulatory loop under clinically relevant conditions. Across 15 biomarkers (n > 6 per group), no significant differences were observed between the two devices.
Wenji Sun +9 more
wiley +1 more source
This mixed methods study aimed to: (i) identify treatment expectations held by individuals with a ventricular assist device (VAD), (ii) assess the extent to which these expectations have been met, and (iii) examine how treatment expectations relate to VAD‐specific health‐related quality of life (HRQoL) ABSTRACT Objectives Treatment expectations ...
Simon Felix Zerth +10 more
wiley +1 more source
How Formal and Informal Nurse Leaders Enact Shared Implementation Leadership in a Hospital Setting
ABSTRACT Aim To describe how implementation leadership manifests among formal and informal point of care nurse leaders during a successful evidence‐based practice implementation. Design A collective case study. Methods A conceptual framework on shared implementation leadership guided the study. Two units known for strong implementation were selected as
Sonia Angela Castiglione +4 more
wiley +1 more source

